Andrea Vecchione Selected Research

Carcinogens

1/2012	Stathmin is dispensable for tumor onset in mice.
4/2008	Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.
9/2007	Take your "M" time.
3/2007	Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.
8/2005	Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
3/2005	Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
3/2004	Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
9/2003	Regression of upper gastric cancer in mice by FHIT gene delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Vecchione Research Topics

Disease

54	Neoplasms (Cancer) 05/2022 - 01/2003
14	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2003
9	Carcinogenesis 01/2019 - 01/2003
6	Carcinoma (Carcinomatosis) 03/2022 - 11/2004
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
4	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 05/2010
2	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 05/2008
2	Adenocarcinoma of Lung 03/2022 - 12/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 05/2011
2	Disease Progression 01/2021 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 07/2017
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 05/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 11/2004
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 06/2013
2	Wounds and Injuries (Trauma) 08/2014 - 05/2014
2	Leukemia 05/2010 - 11/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2008 - 11/2004
2	Esophageal Neoplasms (Esophageal Cancer) 12/2006 - 10/2004
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2022
1	Drug-Related Side Effects and Adverse Reactions 03/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Immunoglobulin G4-Related Disease 11/2021
1	Pleural Effusion (Pleural Effusions) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 07/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	COVID-19 04/2020
1	Severe Acute Respiratory Syndrome 04/2020
1	Coronavirus Infections 04/2020
1	Adenocarcinoma 01/2020
1	Endometrial Hyperplasia 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

17	MicroRNAs (MicroRNA)IBA 05/2022 - 02/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
8	CarcinogensIBA 01/2012 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2005
6	Histidine (L-Histidine)FDA Link 11/2004 - 02/2003
5	Pharmaceutical PreparationsIBA 02/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2021 - 11/2003
4	nitrosobenzylmethylamineIBA 03/2005 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 11/2006
3	Biological ProductsIBA 03/2022 - 03/2003
3	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2004
3	CarbonIBA 10/2021 - 01/2020
3	StathminIBA 01/2019 - 01/2005
3	Phosphotransferases (Kinase)IBA 05/2014 - 03/2005
3	NitrosaminesIBA 01/2012 - 11/2004
3	fragile histidine triad proteinIBA 08/2005 - 03/2004
2	A-Form DNA (A-DNA)IBA 03/2022 - 11/2003
2	Hormones (Hormone)IBA 01/2022 - 01/2021
2	Cyclin DIBA 01/2022 - 10/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2020
2	AutoantibodiesIBA 12/2021 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2019
2	NucleotidesIBA 01/2020 - 11/2003
2	Histones (Histone)IBA 01/2018 - 11/2003
2	CytokinesIBA 08/2014 - 12/2010
2	Indicators and Reagents (Reagents)IBA 05/2014 - 02/2005
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2013 - 05/2010
2	CyclinsIBA 05/2010 - 03/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 10/2008 - 03/2008
2	ZincIBA 10/2004 - 01/2003
1	Bortezomib (Velcade)FDA Link 03/2022
1	HydrogelsIBA 03/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	elastin microfibril interface located protein (emilin)IBA 01/2022
1	GenieIBA 12/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	SteroidsIBA 11/2021
1	palbociclibIBA 10/2021
1	S-Adenosylmethionine (Ademetionine)IBA 10/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Sp1 Transcription FactorIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	LigandsIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	trkB ReceptorIBA 01/2020
1	SolutionsIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Ubiquitin-Specific ProteasesIBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	EnzymesIBA 01/2019
1	PlatinumIBA 01/2019

Therapy/Procedure

13	Therapeutics 12/2021 - 03/2004
3	Drug Therapy (Chemotherapy) 03/2022 - 06/2013
3	Immunotherapy 12/2021 - 01/2019
2	Precision Medicine 02/2022 - 01/2020
1	Radiotherapy 01/2021